Post Polycythemia Myelofibrosis (PPV MF)
2 clinical trials · Condition
◉ Watch Post Polycythemia Myelofibrosis (PPV MF)
| Record | Firm | Date |
|---|---|---|
| Managed Access Programs for INC424, Ruxolitinib (NCT04745637) | Novartis Pharmaceuticals |
Track Post Polycythemia Myelofibrosis (PPV MF) automatically
Every clearance here is in the API, with alerts when new ones post.